TY - JOUR
T1 - Selection and characterization of botanical natural products for research studies
T2 - A NaPDI center recommended approach
AU - Kellogg, Joshua J.
AU - Paine, Mary F.
AU - McCune, Jeannine S.
AU - Oberlies, Nicholas H.
AU - Cech, Nadja B.
N1 - Funding Information:
This project was supported by the National Institutes of Health via the National Center for Complementary and Integrative Health, specifically the Center of Excellence for Natural Product Drug Interaction Research (NaPDI Center, U54 AT008909). JSM was supported in part by the National Cancer Institute [R01 CA182963]. MFP was supported in part by the National Institute of General Medical Sciences [R01 GM077482]. We thank the following individuals for insightful comments and helpful discussions: Dr D. Craig Hopp, NCCIH Program Officer; Dr Amy Roe, Principal Toxicologist at Procter and Gamble; Dr Huzefa Raja, research scientist at the University of North Carolina at Greensboro; Tyler Graf, research scientist at the University of North Carolina at Greensboro; and Dr Danny D. Shen, Professor of Pharmaceutics at the University of Washington. We would like to thank Matt Bryant and Cindy Graf for their expertise and assistance in designing the workflow figures presented here. The high-resolution mass spectrometry data were collected at the Triad Mass Spectrometry Facility at the University of North Carolina at Greensboro (http://chem.uncg.edu/triadmslab/).
Funding Information:
Dr Nadja B. Cech is the Patricia A. Sullivan Distinguished Professor of Chemistry at the University of North Carolina at Greensboro (UNCG). She has had a lifelong interest in the use of plants for medicine, stemming from her involvement as a child in establishing one of the world's largest medicinal plant and seed companies, a company still operated by her family today. Dr Cech leads a dynamic research group at UNCG, for which a major focus in the development of metabolomics as a tool to understand synergy and complexity in biologically active botanical natural products. This work has been continuously funded by the National Institutes of Health for more than 15 years, and was awarded the Jack L. Beal Award from the Journal of Natural Products in 2011. Dr Cech is a member of the Center of Excellence for Natural Product Drug Interaction Research, and Co-Director of the Medicinal Chemistry Collaborative (https:// mcsquared.uncg.edu/).
Funding Information:
This project was supported by the National Institutes of Health via the National Center for Complementary and Integrative Health, specically the Center of Excellence for Natural Product Drug Interaction Research (NaPDI Center, U54 AT008909). JSM was supported in part by the National Cancer Institute [R01 CA182963]. MFP was supported in part by the National Institute of General Medical Sciences [R01 GM077482]. We thank the following individuals for insightful comments and helpful discussions: Dr D. Craig Hopp, NCCIH Program Officer; Dr Amy Roe, Principal Toxicologist at Procter and Gamble; Dr Huzefa Raja, research scientist at the University of North Carolina at Greensboro; Tyler Graf, research scientist at the University of North Carolina at Greensboro; and Dr Danny D. Shen, Professor of Pharmaceutics at the University of Washington. We would like to thank Matt Bryant and Cindy Graf for their expertise and assistance in designing the workow gures presented here. The high-resolution mass spectrometry data were collected at the Triad Mass Spectrometry Facility at the University of North Carolina at Greensboro (http://chem.uncg.edu/triadmslab/).
Funding Information:
Dr Joshua J. Kellogg obtained his PhD in natural product chem- istry and ethnobotanical nutra- ceuticals from North Carolina State University. He is currently a researcher in the lab of Professor Nadja Cech at the University of North Carolina at Greensboro, investigating the relative contributions of natural product mixtures to antibacte- rial activity. Dr Kellogg is the recipient of an NRSA Post doctoral Fellowship from the National Institutes of Health. His research is centered around the development and application of metabolomic approaches to complex mixture analyses, with a focus on endosymbiotic microorganisms to drive discovery of novel bioactive compounds.
Publisher Copyright:
© 2019 The Royal Society of Chemistry.
PY - 2019/8
Y1 - 2019/8
N2 - Covering: Up to the end of 2018 Dietary supplements, which include botanical (plant-based) natural products, constitute a multi-billion-dollar industry in the US. Regulation and quality control for this industry is an ongoing challenge. While there is general agreement that rigorous scientific studies are needed to evaluate the safety and efficacy of botanical natural products used by consumers, researchers conducting such studies face a unique set of challenges. Botanical natural products are inherently complex mixtures, with composition that differs depending on myriad factors including variability in genetics, cultivation conditions, and processing methods. Unfortunately, many studies of botanical natural products are carried out with poorly characterized study material, such that the results are irreproducible and difficult to interpret. This review provides recommended approaches for addressing the critical questions that researchers must address prior to in vitro or in vivo (including clinical) evaluation of botanical natural products. We describe selection and authentication of botanical material and identification of key biologically active compounds, and compare state-of-the-art methodologies such as untargeted metabolomics with more traditional targeted methods of characterization. The topics are chosen to be of maximal relevance to researchers, and are reviewed critically with commentary as to which approaches are most practical and useful and what common pitfalls should be avoided.
AB - Covering: Up to the end of 2018 Dietary supplements, which include botanical (plant-based) natural products, constitute a multi-billion-dollar industry in the US. Regulation and quality control for this industry is an ongoing challenge. While there is general agreement that rigorous scientific studies are needed to evaluate the safety and efficacy of botanical natural products used by consumers, researchers conducting such studies face a unique set of challenges. Botanical natural products are inherently complex mixtures, with composition that differs depending on myriad factors including variability in genetics, cultivation conditions, and processing methods. Unfortunately, many studies of botanical natural products are carried out with poorly characterized study material, such that the results are irreproducible and difficult to interpret. This review provides recommended approaches for addressing the critical questions that researchers must address prior to in vitro or in vivo (including clinical) evaluation of botanical natural products. We describe selection and authentication of botanical material and identification of key biologically active compounds, and compare state-of-the-art methodologies such as untargeted metabolomics with more traditional targeted methods of characterization. The topics are chosen to be of maximal relevance to researchers, and are reviewed critically with commentary as to which approaches are most practical and useful and what common pitfalls should be avoided.
UR - http://www.scopus.com/inward/record.url?scp=85070962171&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85070962171&partnerID=8YFLogxK
U2 - 10.1039/c8np00065d
DO - 10.1039/c8np00065d
M3 - Review article
C2 - 30681109
AN - SCOPUS:85070962171
SN - 0265-0568
VL - 36
SP - 1196
EP - 1221
JO - Natural Product Reports
JF - Natural Product Reports
IS - 8
ER -